These insights underline the therapeutic potential of GBCP in targeting cervical cancer and highlight the need for future studies to explore its molecular mechanisms, particularly its influence on pathways like PI3K/AKT, MAPK/ERK, JNK, and NF-κB (48, 49). The gene discussed is AKT1; the disease is cervical cancer.